|
注册号: Registration number: |
ChiCTR2300075761 |
|
最近更新日期: Date of Last Refreshed on: |
2024-02-16 15:07:05 |
|
注册时间: Date of Registration: |
2023-09-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
精准重复经颅磁刺激治疗对抑郁障碍的疗效及认知功能的影响 |
|
Public title: |
Efficacy of precise repetitive transcranial magnetic stimulation therapy for Major depressive disorder and the effects on cognitive function |
|
注册题目简写: |
精准rTMS对MDD的疗效及认知功能的影响 |
|
English Acronym: |
The effect of precise rTMS on the efficacy and cognitive function of MDD |
|
研究课题的正式科学名称: |
精准重复经颅磁刺激治疗对抑郁障碍的疗效及认知功能的影响 |
|
Scientific title: |
Efficacy of precise repetitive transcranial magnetic stimulation therapy for Major depressive disorder and the effects on cognitive function |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
朱娜 |
研究负责人: |
朱娜 |
|
Applicant: |
Zhu Na |
Study leader: |
Zhu Na |
|
申请注册联系人电话: Applicant telephone: |
+86 137 6140 8662 |
研究负责人电话:
Study leader's |
+86 137 6140 8662 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhuna1987524@aliyun.com |
研究负责人电子邮件: Study leader's E-mail: |
zhuna1987524@aliyun.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市浦东新区三林镇三林路165号 |
研究负责人通讯地址: |
上海市浦东新区三林镇三林路165号 |
|
Applicant address: |
165, Sanlin Road, Sanlin Town, Pudong New Area, Shanghai |
Study leader's address: |
165, Sanlin Road, Sanlin Town, Pudong New Area, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市浦东新区精神卫生中心 |
||
|
Applicant's institution: |
Shanghai Pudong New Area Mental Health Center |
||
|
研究负责人所在单位: |
上海市浦东新区精神卫生中心 |
||
|
Affiliation of the Leader: |
Shanghai Pudong New Area Mental Health Center |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
PDJWLL2023001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市浦东新区精神卫生中心伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Pudong New Area Mental Health Center |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-02-22 00:00:00 | ||
|
伦理委员会联系人: |
张洁纯 |
||
|
Contact Name of the ethic committee: |
Zhang Jiechun |
||
|
伦理委员会联系地址: |
上海市浦东新区三林镇三林路165号 |
||
|
Contact Address of the ethic committee: |
165, Sanlin Road, Sanlin Town, Pudong New Area, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 138 1790 7473 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市浦东新区精神卫生中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Pudong New Area Mental Health Center |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区三林镇三林路165号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
165, Sanlin Road, Sanlin Town, Pudong New Area, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市浦东新区科技和经济委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Pudong New Area Science and Technology and Economic Commission |
||||||||||||||||||||||
|
研究疾病: |
抑郁障碍 |
||||||||||||||||||||||
|
Target disease: |
Major depressive disorder |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
磁共振导航系统引导基于个性化3D打印定位器的精准rTMS治疗应用于抑郁障碍的临床症状及认知损害的疗效,有望成为提高抗抑郁疗效的重要手段之一。 |
||||||||||||||||||||||
|
Objectives of Study: |
The magnetic resonance navigation system guides the accurate rTMS treatment based on personalized 3D printing positioner to the clinical symptoms and cognitive impairment , and is expected to become one of the important means to improve the efficacy of major depression disorder |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1、近三个月内有药物或酒精依赖等影响认知功能; 2、有严重躯体疾病、心脏起搏器或植入药物泵等; 3、有严重消极观念和行为; 4、孕妇; 5、接受过ECT治疗无效; 6、任何神经系统疾病,包括颅内伤、癫痫、帕金森等; 7、颅内有金属植入物;使用抗惊厥药物; 8、认知测试之前的12小时内使用苯二氮䓬类药物及8小时内饮酒。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Within the past three months, there has been medication or alcohol dependence that affects cognitive function; 2. Serious physical illness, pacemaker or implanted drug pump, etc; 3. Serious negative attitudes and behaviors; 4. Pregnant women; 5. Received ECT treatment but ineffective; 6. Any neurological disease, including intracranial injury, epilepsy, Parkinson's disease, etc; 7. There are metal implants in the skull; Using anticonvulsant drugs; 8. Use benzodiazepines within 12 hours prior to cognitive testing and drink alcohol within 8 hours. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-10-01 00:00:00至 To 2026-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-10-01 00:00:00 至 To 2026-09-29 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
根据随机分组表依次分组,将由计算机软件产生的随机数字(区组随机化)与序号对应组成的随机数字序列,所有数字指定为A组(常规rTMS干预组)、B组(精准rTMS干预组),C组(伪刺激rTMS干预组)并记录在案。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
According to the randomization table, the random numbers generated by the computer software (block randomization) and the sequence of random numbers corresponding to the serial number are designated as group A (routine rTMS intervention group), group B (precise rTMS intervention group), and group C (pseudo-stimulus rTMS intervention group) and recorded. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
单盲 |
|
Blinding: |
Single blinded |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
项目结束后1年共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Raw data is shared 1 year after project completion |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |